Latest news
{{'2026-03-09T12:36:24Z' | dateFormatFilter}}
Novo Nordisk expands US patient access to FDA-approved semaglutide medicines through Hims & Hers in response to a shift in their US GLP-1 business model
{{'2026-03-02T15:55:42Z' | dateFormatFilter}}
Election of employee representatives to the Board of Directors of Novo Nordisk A/S
{{'2026-03-02T09:00:00Z' | dateFormatFilter}}
Novo Nordisk announces more than 400 million euro expansion in its manufacturing facility in Athlone, Ireland
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
